-

Hagens Berman Announces Preliminary Court Approval in Historic NCAA Name, Image and Likeness Litigation

Law firm celebrates monumental victory for NCAA college athletes, culminating a 20-year legal fight

OAKLAND, Calif.--(BUSINESS WIRE)--A federal judge today granted preliminary approval to a historic $2.78 billion settlement with the NCAA on behalf of hundreds of thousands of current and former student-athletes at Division I schools, culminating a long legal battle fought by law firm, Hagens Berman.

The antitrust class-action lawsuit against the NCAA will bring historic changes to college sports and will allow college athletes to be fairly compensated for the use of their name, image and likeness (NIL) in what has become a multibillion-dollar industry. The total value of new payments and benefits to college athletes is expected to exceed $20 billion over the next 10 years, making it one of the largest antitrust class-action settlements in history.

“We are pleased that we are one step closer to a revolutionary change in college athletics that will allow billions in revenue sharing,” said Steve Berman, managing partner and co-founder of Hagens Berman.

The preliminarily approved settlement resolves three pending antitrust lawsuits, House v. NCAA, Hubbard v. NCAA, and Carter v. NCAA. As part of the settlement, the NCAA and its conferences will pay more than $2.75 billion in damages to college athletes over a 10-year period, eliminate rules prohibiting schools from making direct payments to athletes, and dramatically expand the availability of compensation and benefits available to athletes. This includes eliminating restrictions on the number of available athletic scholarships across all Division I sports.

What’s Next?

Following today’s preliminary approval, there will be a final approval hearing on April 7, 2025. Notice to the class begins two weeks from today, on Oct. 18, 2024, and will continue on a rolling basis.

The claims period, during which class members will be eligible to file claims also begins Oct. 18, 2024, and ends Jan. 31, 2025. Class member athletes will need to update their contact information and payment method, and file their claim by this date. Jan. 31, 2025 also marks the deadline by which any class member needs to object or opt-out, should they choose to do so.

Find out more about the class-action lawsuit against the NCAA and its member conferences.

Hagens Berman is a global plaintiffs’ rights complex litigation law firm with a tenacious drive for achieving actual results for those harmed by corporate negligence and fraud. Since its founding in 1993, the firm’s determination has earned it numerous national accolades, awards and titles of “Most Feared Plaintiff’s Firm,” MVPs and Trailblazers of class-action law. The firm’s cases have recovered more than $320 billion for its clients. More about the law firm and its successes can be found at www.hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contacts

Media Contact
Ash Klann
pr@hbsslaw.com
206-268-9363

Hagens Berman


Release Summary
A federal judge today granted preliminary approval to a historic $2.78 billion settlement with the NCAA, according to Hagens Berman.
Release Versions

Contacts

Media Contact
Ash Klann
pr@hbsslaw.com
206-268-9363

Social Media Profiles
More News From Hagens Berman

Hagens Berman: Lawsuit Details Excessive Harassment and Employment Retaliation at Snohomish County Juvenile Detention Center

SEATTLE--(BUSINESS WIRE)--Snohomish Co. has been sued for retaliation after a former officer reported harassment at Denney Juvenile Justice Center, according to Hagens Berman....

Hagens Berman Investigating Corcept Therapeutics (CORT): Shares Fall After Report That FDA Warned Against Relacorilant Drug Application Filing

SAN FRANCISCO--(BUSINESS WIRE)--Hagens Berman, a national shareholder rights law firm, is investigating whether Corcept Therapeutics Inc. (NASDAQ: CORT) misled investors about relacorilant’s efficacy and commercial prospects. Corcept is under renewed scrutiny after Reuters reported on Jan. 30, 2026, that the FDA had warned the company “on several occasions” not to submit its application for relacorilant, its proposed treatment for hypercortisolism. The report sent Corcept shares down, wiping ou...

Hagens Berman: Homebuyers Sue Rocket Mortgage and Affiliated Companies in Class Action Alleging Illegal Practices Inflating Home Prices

DETROIT--(BUSINESS WIRE)--A class-action lawsuit alleges homebuyers were illegally steered to use Rocket Mortgage, to their detriment, according to attorneys at Hagens Berman....
Back to Newsroom